Clinical TrialsSearch results
Number of results: 832
Other
- Rituximab + standard CHOP (R S-CHOP) vs Rituximab + bi-weekly CHOP (R Bi-CHOP) RCT(phase II/III) low-grade B-cell lymphoma at advanced stage (LowBNHL-RS/BiCHOP-P2/3) (JCOG0203)
- Untreated CD20-positive low-grade B-cell lymphoma at advanced stage
- Japan Clinical Oncology Group(JCOG)
- 2005-07-30
Other
- Risk Factors and Therapies for Gastric Variceal Bleeding in Japan:retrospective study
- Gastric fundal varices without history of bleeding
- National Hospital Organization Head quarter
- 2007-09-01
Other
- Risk Factors and Therapies for Gastric Variceal Bleeding in Japan:prospective study
- Patients with ruptured gastric fundal varices
- National Hospital Organization Head quarter
- 2007-09-01
Other
- Reserch Non-Helicobacter pylori Helicobacter infection
- Gastric MALT lymphoma, intractable peptic ulcer
- Suzuki Hidekazu
- 2020-09-02
Not yet recruiting
- Research to develop diagnostic and therapeutic methods for cancer of the renal pelvis and ureter
- Cancer of the renal pelvis and ureter
- Hayakawa Nozomi
- 2022-12-09
Other
- Research study of QOL with leukotriene receptor antagonist ,pranlukast in asthmatic patients by use of Asthma Health Questionnaire-Japan QOL (AHQ-JAPAN QOL)
- Asthma
- Asthma QOL Research Study Group
- 2007-06-01
Recruiting
- Research on the safety of hyperthermic chemotherapy administered at the time of resection of disseminated lesions for pleural dissemination of malignant tumors occurring in children and AYA generations
- pleural dissemination of malignant tumor
- Kitagawa Norihiko
- 2024-03-27
Not yet recruiting
- Research on prevention of oral mucositis using sesame oil
- central nervous system lymphoma
- TADERA Noriyuki
- 2023-09-07
Other
- Research for the international hermonization of molecular responce criteria in chronic myelogenous leukemia
- chronic myeloid leukemia
- Kanto CML Study Group
- 2009-03-03
Completed
- REMAP-CAP:Randomized,Embedded,Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia Immune Modulation-2 Domain
- Patients with proven COVID-19 admitted to hospital, as moderate state
- Fujitani Shigeki
- 2021-03-25